Benjamin Linas, MD
Associate Professor
Boston University School of Medicine
Dept of Medicine
Infectious Diseases

MD, New York University School of Medicine
MPH, Harvard School of Public Health



Dr. Linas is a national leader in hepatitis-C virus (HCV) infection and HCV/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods. Dr. Linas has an excellent track record of productivity, ample funding from the NIH and CDC, and a growing core of successful trainees. Dr. Linas directs the HIV/HCV core of the Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV, funded by the National Institute on Drug Abuse (NIDA) in collaboration with Cornell, U Penn and Miami.

Associate Professor
Boston University School of Public Health
Epidemiology





Researching Effective Strategies to Prevent Opiod Death(RESPOND)
06/01/2018 - 03/31/2023 (PI)
NIH-NIDA
1R01DA046527-01

A Cluster RCT to Increase HIV Testing in Substance Use Treatment Programs
09/01/2016 - 07/31/2021 (PI)
Trustees of Columbia University NIH-NIDA

Lifespan/Tufts/brown Center for AIDS Research (CFAR): Core B Developmental (Pilot Projects)
07/01/2016 - 06/30/2019 (PI)
Miriam Hospital NIH-NIAID

TO#3 Strategic Timing of Antiretroviral Treatment (START) - INSIGHT
12/01/2010 - 05/31/2019 (PI)
Institute for Clinical Research, Inc. NIH-NIAID

Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health..
07/01/2015 - 04/30/2019 (PI)
Cornell University NIH-NIDA
5P30DA040500-04

Economic Modeling for HIV, Viral Hepatitis, STD, TB and School Health
09/30/2014 - 09/29/2018 (PI)
Harvard School of Public Health CDC

Health Economics of Substance Abuse and HCV/HIV Treatment in the Era of Integrated Health Care - …
09/01/2017 - 04/30/2018 (PI)
Weill Cornell Medical College NIH-NIDA

Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment Programs
02/15/2015 - 01/31/2018 (PI)
Cornell University NIH-NIDA

Intensive Models of HCV Care for Injection Drug Users
07/15/2012 - 06/30/2017 (PI)
AlbertEinsteinCllgeOfMed of Yeshiva U. NIH-NIDA

Simulation Modeling to Improve HIV/HCV Screening, Treatment & Care - Supplement
06/01/2014 - 05/31/2017 (PI)
NIH-NIDA
5R01DA031059-04

Showing 10 of 15 results. Show All Results


Yr Title Project-Sub Proj Pubs
2018 Researching Effective Strategies to Prevent Opioid Death (RESPOND) 1R01DA046527-01
2018 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) 5P30DA040500-04-6229 1
2017 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) 5P30DA040500-03-6229 1
2016 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) 5P30DA040500-02-6229 1
2015 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) 1P30DA040500-01-6229 1
2014 Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care 3R01DA031059-03S1 13
2014 Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care 5R01DA031059-03 13
2013 Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care 5R01DA031059-02 13
2012 Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care 1R01DA031059-01A1 13
2011 Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs 5K01AI073193-05 6
Showing 10 of 14 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Leech AA, Burgess JF, Sullivan M, Kuohung W, Horný M, Drainoni ML, Christiansen CL, Linas BP. Cost-effectiveness of preexposure prophylaxis for HIV prevention for conception in the United States. AIDS. 2018 Nov 28; 32(18):2787-2798.View Related Profiles. PMID: 30234602.
     
  2. Assoumou SA, Wang J, Tasillo A, Eftekhari Yazdi G, Tsui JI, Strick L, Linas BP. Hepatitis C Testing and Patient Characteristics in Washington State's Prisons Between 2012 and 2016. Am J Prev Med. 2018 Nov 12.View Related Profiles. PMID: 30467088.
     
  3. Barocas JA, White LF, Wang J, Walley AY, LaRochelle MR, Bernson D, Land T, Morgan JR, Samet JH, Linas BP. Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis. Am J Public Health. 2018 Dec; 108(12):1675-1681.View Related Profiles. PMID: 30359112; DOI: 10.2105/AJPH.2018.304673;.
     
  4. Shelton BA, Sawinski D, Linas BP, Reese PP, Mustian M, Hungerpiller M, Reed RD, MacLennan PA, Locke JE. Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation. Am J Transplant. 2018 Oct; 18(10):2483-2495. PMID: 30058218.
     
  5. Epstein RL, Sabharwal V, Wachman EM, Saia KA, Vellozzi C, Hariri S, Linas BP. Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care. J Pediatr. 2018 Dec; 203:34-40.e1.View Related Profiles. PMID: 30170857.
     
  6. Wurcel AG, Burke DJ, Wang JJ, Engle B, Noonan K, Knox TA, Kim AY, Linas BP. The Burden of Untreated HCV Infection in Hospitalized Inmates: a Hospital Utilization and Cost Analysis. J Urban Health. 2018 Aug; 95(4):467-473. PMID: 30027427.
     
  7. Barocas JA, Tasillo A, Eftekhari Yazdi G, Wang J, Vellozzi C, Hariri S, Isenhour C, Randall L, Ward JW, Mermin J, Salomon JA, Linas BP. Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States. Clin Infect Dis. 2018 Aug 01; 67(4):549-556.View Related Profiles. PMID: 29420742.
     
  8. Linas BP. Commentary on Bansback et al. (2018): Estimating the cost of stigma against injection. Addiction. 2018 Jul; 113(7):1274-1275. PMID: 29883035.
     
  9. Chow FC, Wilson MR, Wu K, Ellis RJ, Bosch RJ, Linas BP. Stroke incidence is highest in women and non-Hispanic blacks living with HIV in the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials cohort. AIDS. 2018 Jun 01; 32(9):1125-1135. PMID: 29746317.
     
  10. Linas BP, Nolen S. A Guide to the Economics of Hepatitis C Virus Cure in 2017. Infect Dis Clin North Am. 2018 06; 32(2):447-459. PMID: 29778265.
     
Showing 10 of 72 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 72 publications over 16 distinct years, with a maximum of 22 publications in 2018

YearPublications
19961
19971
19981
20002
20062
20082
20093
20101
20112
20121
20132
20149
20155
20167
201711
201822
Contact for Mentoring:

771 Albany St
Boston MA 02118
Google Map


Linas's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department